Pleco Therapeutics receives funding from Oost NL

NIJMEGEN, March 1st, 2021 – Pleco Therapeutics has been granted financial support by the ION+ Innovation fund for small and medium-sized businesses in the province of Gelderland. The fund is managed by Oost NL, backed by the EU and the..

Read more..

Best wishes for 2021

We hope you and your family had a pleasant Holiday season. We wish to thank you for your support during a difficult 2020 and extend our best wishes for the New Year. At Pleco, we had to overcome some obstacles..

Read more..

R&D activities have started

Pleco Therapeutics has initiated a sponsored research program at The University of Texas MD Anderson Cancer Center based upon intellectual property developed at MD Anderson and licensed by Pleco. Despite the ongoing Covid pandemic, Pleco Therapeutics is now taking the..

Read more..

Pleco team present at LSX World Congress

We are pleased to inform you that our board members Ivo Timmermans, Rudi Jansen and Gerben de Rijk will attend the 7th Annual LSX World Congress. This meeting will be delivered virtually, from 1 to 12 February. Feel free to..

Read more..

LSX World Congress in London

We are excited to share that our board members Ivo Timmermans and Rudi Jansen will attend the LSX World Congress in London. Our CEO Ivo Timmermans will give a presentation at the Biotech Showcase event on 4th February at 15.45..

Read more..

CPHI Worldwide in Frankfurt

November 5th – 7th, our Chief Business Officer Rudi Jansen will be attending the Convention on Pharmaceutical Ingredients (CPHI Worldwide) in Frankfurt, Germany. With 45,000 attendees and 2,500 exhibitors, CHPI is the leading pharmaceutical networking exhibition in the world. If..

Read more..